I liked your post as it mirrored some of my thoughts. Although your relatively short projected timeline (3 yrs) and MCap (20B) to match the big boys is in my opinion a tad over ambitious. Mainly because of your timing 3 years.
I got in early with BRN and PLS at around the same time. Both have had remarkable growth , but PLS growth has definitely outshone BRN. Why, because of the revenue hitting the books and the cash flow it generates. Because of the offtake agreements just locked in the future revenue growth can't be ignored.
With BRN, which in my opinion is just as promising (even more so), The initial factor limiting the share price growth will be when and how much revenue hits the books. It will be a true milestone when this revenue matches the companies operational and developmental cash burn. Last years (2021) annual operating expenses were 21m. This years report (2022) is due late February , lets see what the latest operational expenses are this year. 25M wouldn't surprise me.
Its hard to imagine revenue matching the cash burn rate by the 2023 Annual report. But maybe?
I expect the following two years will be much better. But even 600M revenue a year will not get us to a MCap of 20B. Remember revenue is not profitability.
I suspect that it will just take more time.
Hope I'm wrong. I would love to be surprised.
Just my opinion, as always DYOR.
cheers Lies
BRN Price at posting:
74.5¢ Sentiment: Buy Disclosure: Held
(20min delay)
